TPTX » Topics » Exhibit Index

This excerpt taken from the TPTX 8-K filed Oct 7, 2009.

Exhibit Index

 

 

Filed

 

Exhibit

 

Here

Incorporated by Reference

No.

Exhibit Description

with

Form

File No.

Exhibit

Filing Date

Filed By

4.7

Form of Stock Certificate for Raptor

X

 

 

 

 

 

 

 

 

 

 

This excerpt taken from the TPTX 8-K filed Dec 20, 2006.

EXHIBIT INDEX

Exhibit
Number

 

Description

 

10.1

 

Employment Agreements by and between Neil M. Kurtz, M.D. and TorreyPines Therapeutics, Inc. dated December 14, 2006.

 

10.2

 

Employment Agreements by and between Evelyn Graham and TorreyPines Therapeutics, Inc. dated December 14, 2006.

 

10.3

 

Employment Agreements by and between Craig Johnson and TorreyPines Therapeutics, Inc. dated December 14, 2006.

 

 

 

 

7



This excerpt taken from the TPTX 8-K filed Dec 13, 2006.

EXHIBIT INDEX

23.1

 

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm to TorreyPines Therapeutics, Inc. (now known as TPTX, Inc.). Filed herewith.

 

 

 

99.1

 

The audited financial statements of TorreyPines Therapeutics, Inc. (now known as TPTX, Inc.) as of December 31, 2004 and 2005, and for the three years in the period ending December 31, 2005, including the report of its independent registered public accounting firm, Ernst & Young LLP.  Filed herewith.

 

 

 

99.2

 

Unaudited condensed financial statements of TorreyPines Therapeutics, Inc. (now known as TPTX, Inc.) as of September 30, 2006 and for the nine months ended September 30, 2006 and 2005. Filed herewith.

 

 

 

99.3

 

Unaudited pro forma condensed combined financial statements describing the pro forma effect of the business combination on TorreyPines Therapeutics, Inc. (formerly Axonyx Inc.)(i) unaudited statements of operations for the nine months ended September 30, 2006 and the year ended December 31, 2005 and (ii) unaudited balance sheet as of September 30, 2006. Filed herewith.

 

4



This excerpt taken from the TPTX 8-K filed Dec 13, 2006.

EXHIBIT INDEX

Exhibit Number

 

Description

16.1

 

Letter from Eisner LLP to the Securities and Exchange Commission, dated December 13, 2006.

 

5



This excerpt taken from the TPTX 8-K filed Oct 10, 2006.

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

2.1

 

Agreement and Plan of Merger and Reorganization, dated as of June 7, 2006, by and among Axonyx Inc., Autobahn Acquisition, Inc. and TorreyPines Therapeutics, Inc. filed with the Securities and Exchange Commission on July 25, 2006 as Annex A to the Registration Statement on Form S-4 (Reg. No. 333-136018)

2.2

 

Amendment No. 1 to Agreement and Plan of Merger and Reorganization, dated as of August 25, 2006, by and among Axonyx Inc., Autobahn Acquisition, Inc. and TorreyPines Therapeutics, Inc. filed with the Securities and Exchange Commission on August 25, 2006 as Annex A to Amendment No. 1 to the Registration Statement on Form S-4 (Reg. No. 333-136018)

3.1

 

Certificate of Incorporation of TorreyPines Therapeutics, Inc.

3.2

 

Bylaws of TorreyPines Therapeutics, Inc.

3.3

 

Certificate of Amendment filed with the Secretary of State of the State of Nevada effecting a 1-for-8 reverse stock of Axonyx Inc. common stock and changing the name of the corporation from Axonyx Inc. to TorreyPines Therapeutics, Inc.

3.4

 

Articles of Conversion filed with the Secretary of State of the State of Nevada changing the state of incorporation

3.5

 

Certificate of Conversion filed with the Secretary of State of the State of Delaware

10.1

 

Development and License Agreement between TorreyPines Therapeutics, Inc. (formerly Neurogenetics, Inc.) and Eli Lilly and Company, effective as of April 21, 2003.

10.2

 

Research and License Agreement by and between TorreyPines Therapeutics, Inc. and Life Science Research Israel Ltd. dated as of May 10, 2004.

10.3

 

Cooperation Agreement by and between TorreyPines Therapeutics, Inc. and Eisai Co. Ltd. dated as of October 1, 2005.

10.4

 

Collaboration Agreement by and between TorreyPines Therapeutics, Inc. and Eisai Co. Ltd. dated as of February 28, 2005.

10.5

 

License Agreement by and between TorreyPines Therapeutics, Inc. and University of Iowa Research Foundation dated as of May 10, 2006.

10.6

 

Letter Agreement by and between TorreyPines Therapeutics, Inc. and Johnson and Johnson Development Corporation dated as of August 24, 2004.

10.7

 

Loan and Security Agreement dated as of September 27, 2005 by and among the TorreyPines Therapeutics, Inc, Oxford Finance Corporation and Silicon Valley Bank.

10.8

 

TorreyPines 2000 Equity Incentive Plan.

10.9

 

Form of Stock Option Agreement under TorreyPines 2000 Equity Incentive Plan.

10.10

 

Lease Agreement by and between TorreyPines Therapeutics, Inc and Slough TPSP LLC dated as of July 18, 2005, which became effective February 10, 2006.

10.11

 

Offer Letter by and between TorreyPines Therapeutics, Inc. and Neil Kurtz dated as of September 19, 2001.

10.12

 

Offer Letter by and between TorreyPines Therapeutics, Inc. and Craig Johnson dated as of November 17, 2003

10.13

 

Form of Indemnity Agreement.

99.1

 

Slide presentation of TorreyPines Therapeutics, Inc.

 

15


This excerpt taken from the TPTX 8-K filed Oct 4, 2006.

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

10.1

 

TorreyPines 2006 Equity Incentive Plan

 

10.2

 

2006 Equity Incentive Plan Form of Stock Option Agreement

 

99.1

 

Press Release dated October 4, 2006.

 

 

 



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki